Sign in Create account
Sign in and upgrade to a paid plan to export announcements as CSV.

Norris Medicines Ltd.

Services · Commercial Services & Supplies

BSE: 524414
₹17.15
▼ -0.90 (-4.99%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
11/100
Weak
Valuation
—/100
Expensive
Momentum
84/100
Bullish

QVM read Momentum-led Quality Weak, Valuation Expensive, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹17 Cr
PE (TTM)
428.8
Industry median 24.9 (183 companies)
Price to Book
-1.1
PEG (TTM)
4.1
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
8.2
Free Cash Flow
₹1 Cr
as of March 31, 2026
Industry median ₹-0 Cr (372 companies)
EPS Growth (YoY)
-29.03%
as of June 30, 2026
Industry median 0.00% (300 companies)
Net Profit Growth (TTM)
103.11%
as of June 30, 2026
Industry median 0.00% (325 companies)
Operating Revenue Growth (TTM)
54.89%
as of June 30, 2026
Industry median 0.00% (317 companies)
Profit Growth (YoY)
-28.06%
as of June 30, 2026
Industry median 2.13% (293 companies)
Revenue Growth (YoY)
-36.51%
as of June 30, 2026
Industry median 7.61% (227 companies)
Current Ratio
0.61
as of March 31, 2026
Industry median 2.48 (345 companies)
Debt to Equity
-1.42
as of March 31, 2026
Industry median 0.06 (315 companies)
Interest Coverage
1.10
as of June 30, 2026
Industry median 2.71 (293 companies)
Net Margin
-42.92%
as of June 30, 2026
Industry median 3.80% (247 companies)
Operating Margin (EBIT)
-42.91%
as of June 30, 2026
Industry median 6.24% (257 companies)
Operating Margin (TTM)
6.13%
as of June 30, 2026
Industry median 4.63% (310 companies)
Return on Assets
1.21%
as of March 31, 2026
Industry median 0.99% (329 companies)
Return on Capital Employed
20.00%
as of March 31, 2026
Industry median 2.68% (300 companies)
Return on Equity
-1.03%
as of March 31, 2026
Industry median 2.11% (328 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (-1.42)
  • No Return on equity is 15% or more (-1.0%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.0%
Low 17.1500 · High 18.0500
1W return
-12.8%
Low 17.1500 · High 20.0600
1M return
14.3%
Low 13.5000 · High 20.0600
52W return
-6.8%
Low 13.5000 · High 20.0600
Lifetime High ₹36.7500 (Feb. 14, 2022)
Lifetime Low ₹2.4500 (May 14, 2020)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
18.2
10D
18.0
20D
17.3
50D
15.9
100D
15.1
200D
15.1

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
94.0%
Month avg. delivery
91.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

17.45
Pivot
First resistance17.75
Second resistance18.35
Third resistance18.65
First support16.85
Second support16.55
Third support15.95
Day RSI52.1
Day MFI81.0
Day MACD1.00
Day MACD signal0.99

Beta

1M-1.64
3M-1.99
1Y-1.99
3Y0.05

Price change analysis

↑ 14.3%
Over 1 Month
LowHigh
13.5020.06
↓ -6.8%
Over 3 Months
LowHigh
13.5020.06
↓ -6.8%
Over 6 Months
LowHigh
13.5020.06
↓ -6.8%
Over 1 Year
LowHigh
13.5020.06
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 428.8 (own history: 115.0–460.0)
Sell Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹1 Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹-0.4000

Ranks #191 of 315 in Commercial Services & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter34.01%
  • Mutual funds0.01%
  • Other DII0.06%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 34.01% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.01% in Jun 2026 qtr

All shareholding details →

Corporate Announcements

All 8 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 AGM/EGM Norris Medicines Ltd - 524414 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 AGM/EGM Norris Medicines Ltd - 524414 - Proceeding Of The Annual General Meeting
29 Sep 2026 Company Update Norris Medicines Ltd - 524414 - Outcome And Proceeding Of The 35Th Annual General Meeting
29 Sep 2026 AGM/EGM Norris Medicines Ltd - 524414 - Shareholder Meeting / Postal Ballot-Outcome of AGM
29 Sep 2026 Company Update Norris Medicines Ltd - 524414 - Scrutinizer''s Report And Voting Results Of The 35Th AGM Of The Company Held 29Th September, 2026
4 Sep 2026 AGM/EGM Norris Medicines Ltd - 524414 - Notice Of 35Th Annual General Meeting Of The Company For The Financial Year 2025-26
4 Sep 2026 Corp. Action Norris Medicines Ltd - 524414 - Intimation Of Book Closure For 35Th AGM Of The Company.
4 Sep 2026 Others Norris Medicines Ltd - 524414 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (-1.0%)
  • Thin net profit margin (-42.9%)
  • Negative shareholder equity (Debt/Equity -1.42) -- accumulated losses exceed paid-in capital
  • Tight liquidity (Current Ratio 0.61)
  • Declining revenue YoY (-36.5%)
  • Declining profit YoY (-28.1%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (428.8) -- priced for continued strong execution
  • Weak interest coverage (1.1x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Norris Medicines Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.